scholarly journals Community navigators for breast and cervical cancer screening and follow-up

2015 ◽  
Vol 10 (S1) ◽  
Author(s):  
Melissa A Simon ◽  
Laura S Tom ◽  
Erika E de la Riva ◽  
Emily L Malin ◽  
Joe Feinglass
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Breast And Cervical Cancer

scholarly journals Depressive symptoms, neuroticism and participation in breast and cervical cancer screening in the UK

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
C L Niedzwiedz ◽  
K A Robb ◽  
S V Katikireddi ◽  
J P Pell ◽  
D J Smith
Keyword(s):  
Breast Cancer ◽  
Cervical Cancer ◽  
Depressive Symptoms ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Breast And Cervical Cancer ◽  
Screening Participation ◽  
The Uk ◽  
Prospective Analyses

Abstract Background Globally, more than 2 million women are diagnosed with breast or cervical cancer every year. Depressive symptoms and personality traits have been implicated in cancer-related mortality, but the potential mechanisms through which these associations may operate are not well understood. We aimed to assess how depressive symptoms and neuroticism are associated with participation in breast and cervical cancer screening. Methods 273 402 women in the UK Biobank cohort who were eligible for breast cancer screening (aged 50-70 years) and/or cervical cancer screening (<65 years) at baseline recruitment (2006-10) and those with follow-up data (2014-March 19) were identified. Depressive symptoms (4 items from Patient Heath Questionnaire) and neuroticism (12 items from Eysenck Personality Inventory Neuroticism Scale) were self-reported at baseline. The primary outcomes were reporting being up to date with breast and cervical cancer screening. For prospective analyses, patterns of screening participation from baseline to follow-up were derived. Logistic regression was used to analyse associations, adjusted for potential confounders. Results More severe depressive symptoms (range 0-12) were associated with reduced screening for breast (OR = 0.960, 95% CI: 0.950,0.970) and cervical cancer (OR = 0.958, 95% CI: 0.950,0.966). Prospective analyses revealed higher baseline depressive symptoms were related to decreased cervical cancer screening at follow-up (OR = 0.955, 95% CI: 0.913,0.999; equivalent to a difference of 4.08% between the highest and lowest depressive symptom score), but not with breast cancer screening. Results for overall neuroticism were inconclusive, but individual neuroticism items including anxiety and nervousness were related to increased screening participation. Conclusions More severe depressive symptoms may act as a barrier for cancer screening participation and could be an indication for more proactive strategies to improve uptake. Key messages Women with more severe depressive symptoms are less likely to be up to date with their breast and cervical cancer screening, which may exacerbate existing health inequalities. Interventions to increase screening participation among women with poor mental health may be merited.

scholarly journals What Women Want: Patient Recommendations for Improving Access to Breast and Cervical Cancer Screening and Follow-up

2014 ◽  
Vol 24 (5) ◽  
pp. 511-518 ◽  
Author(s):  
Daiva M. Ragas ◽  
Narissa J. Nonzee ◽  
Laura S. Tom ◽  
Ava M. Phisuthikul ◽  
Thanh Ha Luu ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Breast And Cervical Cancer

Strategies for follow-up and treatment services in state breast and cervical cancer screening programs

1999 ◽  
Vol 9 (1) ◽  
pp. 42-49 ◽  
Author(s):  
Paula M. Lantz ◽  
Lisa C. Richardson ◽  
Debra J. Macklem ◽  
Lisa R. Shugarman ◽  
Donna B. Knutson ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Programs ◽  
Treatment Services ◽  
Breast And Cervical Cancer

scholarly journals Partnering for Success: Expanding Breast and Cancer Screening in Rural Honduras One Clinic at a Time

2016 ◽  
Vol 2 (3_suppl) ◽  
pp. 24s-25s
Author(s):  
Derek S. Stenquist ◽  
Suyapa Bejarano ◽  
Linda S. Kennedy ◽  
Silvia Portillo ◽  
Ana Barrientos ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
High Risk ◽  
Rural Communities ◽  
Cervical Cancer Screening ◽  
Conflicts Of Interest ◽  
Cancer Education ◽  
Cancer Center ◽  
Breast And Cervical Cancer

Abstract 36 Background: Women in rural Honduras have limited access to cancer education, screening, and care. With village leaders, we piloted breast and cervical cancer screening in El Rosario, Honduras. Our objectives were to improve awareness and access, mitigate barriers, connect community and Honduran providers, and link patients with abnormal findings to cancer treatment. In 2013, health professionals and staff from Norris Cotton Cancer Center at Dartmouth- Hitchcock joined Honduran clinicians and medical students from La Liga Contra el Cáncer for two days of rural cancer screening. Peer educators taught 475 participants from 31 rural communities how to conduct self-breast exams. Of these participants, 238 chose clinical breast exams; 5% were clinically abnormal and 2.9% were referred for services at La Liga with 100% compliance. 34% reported barriers to cervical cancer screening due to distance and lack of transportation. 14.5% tested positive for HPV and 8% were positive for high risk HPV genotypes including 11 of 13 known high risk types. This group has been retested periodically by Pap. The collaborators will return in April 2016 to repeat the study, adding oral and thyroid screening. Genotyping for hrHPV will be onsite with a novel assay for PCR developed at Dartmouth-Hitchcock. Reflex testing with Pap will follow as needed. Follow up will be at La Liga where care is offered for free or at a reduced cost. A similar project for 400 urban factory-workers will also take place in April 2016. Methods: 2-day, multi-modal education and screening outreach run brigade-style combining low-tech primary screening with onsite molecular pathology. Conclusions: Partnerships between local leaders and clinicians are predicted to be essential to project implementation. Targeting populations with education and screening plus building connections to follow up care will provide earlier detection of breast and cervical cancer. We predict that community leadership will be critical to preventing loss to follow-up. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST: Derek S. Stenquist No relationship to disclose Suyapa Bejarano No relationship to disclose Linda S. Kennedy No relationship to disclose Silvia Portillo No relationship to disclose Ana Barrientos No relationship to disclose Suzanne P. Burgos No relationship to disclose Roberto Armando Elvir Zelaya No relationship to disclose Christine Averill No relationship to disclose Emmeline Liu No relationship to disclose Francine de Abreau No relationship to disclose Paul Burchard No relationship to disclose Torrey Gallagher No relationship to disclose Martha Goodrich No relationship to disclose Scottie Eliassen No relationship to disclose Julie Weiss No relationship to disclose Camilo Mandujano No relationship to disclose Jennifer Alford-Teaster No relationship to disclose Gregory J. Tsongalis Research Funding: Illumina, Qiagen, Thermofisher Tracy Onega No relationship to disclose Mary D. Chamberlin No relationship to disclose

Three-year follow-up of women who participated in a prison cervical cancer screening intervention

2005 ◽  
Author(s):  
Ruth Elwood Martin ◽  
Greg Hislop ◽  
Veronika Moravan ◽  
Garry Grams ◽  
Betty Calam
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening
Sign in / Sign up

Export Citation Format

Share Document